NCT03425279 2025-09-23CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With SarcomaBioAtla, Inc.Phase 1/2 Completed245 enrolled
NCT03899805 2025-08-28A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue SarcomasDana-Farber Cancer InstitutePhase 2 Completed57 enrolled 14 charts
NCT04242238 2025-08-28Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic SarcomasMemorial Sloan Kettering Cancer CenterPhase 1 Completed32 enrolled
NCT02815995 2025-06-12Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma SubtypesM.D. Anderson Cancer CenterPhase 2 Completed57 enrolled 18 charts